New natural products of interest under development at the National Cancer Institute
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 1 (2), 91-100
- https://doi.org/10.1007/bf00254042
Abstract
Summary Fourteen new agents of natural products origin which are under development as antitumor agents at the National Cancer Institute are discussed with reference to their sources, structures, antitumor activity, current status, and future prospects as clinically effective agents.Keywords
This publication has 16 references indexed in Scilit:
- Antineoplastic Agents from PlantsAnnual Review of Pharmacology and Toxicology, 1977
- Tumor inhibitors. 119. Baccharin, a novel potent antileukemic trichothecene triepoxide from Baccharis megapotamicaJournal of the American Chemical Society, 1976
- Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoidsJournal of Medicinal Chemistry, 1976
- New antitumor antibiotics, aclacinomycins A and B.The Journal of Antibiotics, 1975
- U-42, 126, a New Antimetabolite Antibiotic: Production, Biological Activity, and Taxonomy of the Producing MicroorganismAntimicrobial Agents and Chemotherapy, 1973
- Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysentericaThe Journal of Organic Chemistry, 1973
- Tumor inhibitors. LXXIV. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordiiJournal of the American Chemical Society, 1972
- Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatusJournal of the American Chemical Society, 1972
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971
- Structures of harringtonine, isoharringtonine, and homoharringtonineTetrahedron Letters, 1970